ILC Dover, a global leader in the development of single-use flexible solutions for pharmaceutical manufacturing,...
The DoverPac® Containment Systems are the global premier products for disposable process and powder containment systems.
Launched from a partnership with multi-national pharmaceutical companies to develop high-containment for active pharmaceutical ingredient (API) production and oral sold dosage processing, DoverPac® is the global standard for containment, reliability, and service.
DoverPac® was designed in collaboration with Eli Lilly to provide high levels of reliable containment during both charging and offloading operations. The system consists of a tough fabric outer restraint and a durable film liner.
One of the key elements of ILC’s DoverPac® line of products is the ArmorFlex® material. These films are custom formulated by ILC to deliver superior elongation performance (nearly 500%) for ruggedness and high strength. This feature, coupled with a unique blend of safe and effective anti-static additives, allows all of the DoverPac® products to deliver reliable high-level containment.
Key features of DoverPac include:
- Demonstrated nanogram containment performance during powder transfer operations (on a task basis using lactose as the surrogate and trained personnel)
- Durable construction (manufactured from rugged ArmorFlex® film developed by ILC Dover
- Peace of mind knowing that every system has been 100% pressure tested and inspected
- Integral sleeves facilitate quick sampling without breaking containment
Lyophilization transforms drug products and substances from a liquid to a stable solid by removing...
ILC Dover Introduces Atmospheric Control Module to Safely Contain Highly-Potent Active Pharmaceutical Ingredients
ILC Dover, a world leader in the innovative design and production of engineered products employing...
A pharmaceutical production line must be safely and efficiently managed above all else. If a...